Track topics on Twitter Track topics that are important to you
EXINI Diagnostics AB EXINI, a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The company's software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is used in analysis of bone scintigraphy; and EXINIheart provides analysis of myocardial perfusion scintigraphy. EXINI's EXINIbrain is used for diagnosing dementia by processing cerebral blood flow scans; and EXINIdat is used for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company provides image analysis, display of images, preselection of hotspot, bone scan index and qualification, Bone scan index report, handling of large databases, and artificial neural networks for increasing accuracy and improving clinical timeflow. It offers products in the fields of oncology, cardiology, and neurology. The company serves in quality, patenting, marketing and publicizing. EXINI is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company EXINI Diagnostics AB
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...